485 related articles for article (PubMed ID: 15553359)
21. Defibrillator for primary prevention in congenital heart disease.
Sueblinvong V; Ovadia M
Pacing Clin Electrophysiol; 2004 Aug; 27(8):1167-9. PubMed ID: 15305972
[TBL] [Abstract][Full Text] [Related]
22. Successful parental use of an automated external defibrillator for an infant with long-QT syndrome.
Divekar A; Soni R
Pediatrics; 2006 Aug; 118(2):e526-9. PubMed ID: 16816007
[TBL] [Abstract][Full Text] [Related]
23. A comprehensive approach to management of ventricular arrhythmias.
Kusumoto F
Cardiol Clin; 2008 Aug; 26(3):481-96, vii. PubMed ID: 18538192
[TBL] [Abstract][Full Text] [Related]
24. Ventricular arrhythmia following alcohol septal ablation for obstructive hypertrophic cardiomyopathy.
Noseworthy PA; Rosenberg MA; Fifer MA; Palacios IF; Lowry PA; Ruskin JN; Sanborn DM; Picard MH; Vlahakes GJ; Mela T; Das S
Am J Cardiol; 2009 Jul; 104(1):128-32. PubMed ID: 19576333
[TBL] [Abstract][Full Text] [Related]
25. The ABCD (Alternans Before Cardioverter Defibrillator) Trial: strategies using T-wave alternans to improve efficiency of sudden cardiac death prevention.
Costantini O; Hohnloser SH; Kirk MM; Lerman BB; Baker JH; Sethuraman B; Dettmer MM; Rosenbaum DS;
J Am Coll Cardiol; 2009 Feb; 53(6):471-9. PubMed ID: 19195603
[TBL] [Abstract][Full Text] [Related]
26. Sudden cardiac death in adults with congenital heart disease.
Yap SC; Harris L
Expert Rev Cardiovasc Ther; 2009 Dec; 7(12):1605-20. PubMed ID: 19954322
[TBL] [Abstract][Full Text] [Related]
27. Implantable cardioverter-defibrillators in patients with hypertrophic cardiomyopathy -- dilemmas and difficulties.
Przybylski A; Małecka L; Pytkowski M; Chojnowska L; Lewandowski M; Sterliński M; Maciag A; Ruzyłło W; Szwed H
Kardiol Pol; 2005 Oct; 63(4):391-7; discussion 398. PubMed ID: 16273479
[TBL] [Abstract][Full Text] [Related]
28. The Italian Implantable Cardioverter-Defibrillator Registry. A survey of the national activity during the years 2001-2003.
Proclemer A; Ghidina M; Cicuttini G; Gregori D; Fioretti PM
Ital Heart J; 2005 Mar; 6(3):272-80. PubMed ID: 15875520
[TBL] [Abstract][Full Text] [Related]
29. [Implantable pacemaker-cardioconverter-defibrillator].
Richter T; Borbola J; Arvay A
Orv Hetil; 1995 Feb; 136(6):295-8. PubMed ID: 7885680
[TBL] [Abstract][Full Text] [Related]
30. Role of implantable cardioverter defibrillator therapy in patients with acquired long QT syndrome: a long-term follow-up.
Mönnig G; Köbe J; Löher A; Wasmer K; Milberg P; Zellerhoff S; Pott C; Zumhagen S; Radu R; Scheld HH; Haverkamp W; Schulze-Bahr E; Eckardt L
Europace; 2012 Mar; 14(3):396-401. PubMed ID: 21979994
[TBL] [Abstract][Full Text] [Related]
31. Role of implantable cardioverter defibrillator therapy in patients with long QT syndrome.
Daubert JP; Zareba W; Rosero SZ; Budzikowski A; Robinson JL; Moss AJ
Am Heart J; 2007 Apr; 153(4 Suppl):53-8. PubMed ID: 17394903
[TBL] [Abstract][Full Text] [Related]
32. [Implantable cardioverter-defibrillator: prevention of sudden cardiac death and impact on survival in patients with malignant ventricular arrhythmias].
Occhetta E; Magnani A; Francalacci G; Perucca A; Sarasso G; Piccinino C; Trevi G
Cardiologia; 1995 Jun; 40(6):419-25. PubMed ID: 8640855
[No Abstract] [Full Text] [Related]
33. Primary prevention of sudden cardiac death: indications for cardioverter-defibrillator implantation.
Botto GL; Proclemer A; Luzi M; Ruffa F; Gorgoglione MG; Ferrari G
Ital Heart J; 2005 Mar; 6(3):210-5. PubMed ID: 15875511
[TBL] [Abstract][Full Text] [Related]
34. Impact of sleep-disordered breathing on life-threatening ventricular arrhythmia in heart failure patients with implantable cardioverter-defibrillator.
Serizawa N; Yumino D; Kajimoto K; Tagawa Y; Takagi A; Shoda M; Kasanuki H; Hagiwara N
Am J Cardiol; 2008 Oct; 102(8):1064-8. PubMed ID: 18929710
[TBL] [Abstract][Full Text] [Related]
35. [Anesthetic management for cardioverter defibrillator implantation in a patient with preoperatively undiagnosed myotonic dystrophy].
Asada M; Suzuki H; Sumitomo M
Masui; 2001 Oct; 50(10):1136-8. PubMed ID: 11712353
[TBL] [Abstract][Full Text] [Related]
36. Relation of 12-lead electrocardiogram patterns to implanted defibrillator-terminated ventricular tachyarrhythmias in hypertrophic cardiomyopathy.
Sherrid MV; Cotiga D; Hart D; Ehlert F; Haas TS; Shen WK; Link MS; Estes NA; Epstein AE; Semsarian C; Daubert JP; Winters SL; Giudici MC; Maron BJ
Am J Cardiol; 2009 Dec; 104(12):1722-6. PubMed ID: 19962483
[TBL] [Abstract][Full Text] [Related]
37. Implantable cardioverter-defibrillators in children.
Werner B; Przybylski A; Kucińska B; Lewandowski M; Szwed H; Wróblewska-Kałuzewska M
Kardiol Pol; 2004 Mar; 60(3):239-46. PubMed ID: 15156219
[TBL] [Abstract][Full Text] [Related]
38. Implantable cardioverter-defibrillators in patients with left ventricular noncompaction.
Kobza R; Jenni R; Erne P; Oechslin E; Duru F
Pacing Clin Electrophysiol; 2008 Apr; 31(4):461-7. PubMed ID: 18373765
[TBL] [Abstract][Full Text] [Related]
39. [Transesophageal ventricular stimulation and ventricular tachycardia in the period before implantation of a cardioverter-defibrillator].
Pella J; Bodnár J; Stancák B; Misíkoá S; Sedlák J; Cizmárik P
Vnitr Lek; 1994 Oct; 40(10):663-6. PubMed ID: 7810086
[TBL] [Abstract][Full Text] [Related]
40. Who are the long-QT syndrome patients who receive an implantable cardioverter-defibrillator and what happens to them?: data from the European Long-QT Syndrome Implantable Cardioverter-Defibrillator (LQTS ICD) Registry.
Schwartz PJ; Spazzolini C; Priori SG; Crotti L; Vicentini A; Landolina M; Gasparini M; Wilde AA; Knops RE; Denjoy I; Toivonen L; Mönnig G; Al-Fayyadh M; Jordaens L; Borggrefe M; Holmgren C; Brugada P; De Roy L; Hohnloser SH; Brink PA
Circulation; 2010 Sep; 122(13):1272-82. PubMed ID: 20837891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
